Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in subjects with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD)
There are no approved oral or non-invasive treatments for GA
Enrollment of approximately 430 GA subjects across multiple centers globally
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.